# Association of COVID-19 infection and vaccination with cardiovascular-related adverse pregnancy outcomes: a population-wide cohort study of 885,156 pregnant women in England and Wales

## Project description

During pregnancy, physiological changes that affect cardiovascular and respiratory systems, along with immunologic alterations, put pregnant women at increased risk of clinically important cardiovascular-related adverse pregnancy outcomes, including gestational diabetes, gestational hypertensive disorders, intrauterine growth restriction and preterm birth1.

Studies have suggested that additional viremia and inflammatory phases of respiratory virus-related infections such as H1N1 influenza, SARS-2003, and more recently SARS-CoV-2, may restrict maternal adaptation by inducing a pro-coagulation stage affecting uteroplacental circulation and fetal  growth, and in turn, further increase the risk of adverse pregnancy outcomes. However, few studies have quantified the risks of rare outcomes such as stillbirth and venous thrombotic events, or explored how these risks differ by time since infection, pregnancy trimester, or secular time period (e.g. SARS-CoV-2 variants and vaccination era). In addition, there is the need for robust evidence to exclude the possible association between COVIDâ€19 vaccines and adverse pregnancy outcomes during pregnancy.

To address these gaps and further advance our understanding of the role played by SARS-CoV-2 infection on adverse pregnancy outcomes in a beyond pandemic era, we leveraged linked electronic health record (EHR) data sources from England and Wales to build a population-wide cohort of women with a record of delivery/birth during the COVID-19 pandemic period. We compared the incidence of cardiovascular-related adverse pregnancy outcomes in women with and without COVID-19 diagnosis and vaccination during pregnancy, accounting for multiple potential confounding factors.

## How to cite this work
> Citation goes here

## Contents

* [View the analysis code and phenotypes used in NHS England's TRE for England](https://github.com/BHFDSC/CCU018_01/tree/main/england)
* [View the analysis code and phenotypes used in the SAIL Databank](https://github.com/BHFDSC/CCU018_01/tree/main/wales)
* [View the code used outside of the environments to prepare tables and figures for publication](https://github.com/BHFDSC/CCU018_01/tree/main/outside)
* [View the final ouput of our analysis](https://github.com/BHFDSC/CCU018_01/tree/main/outside/output)

## Project approval

This is a sub-project of [project CCU018](https://github.com/BHFDSC/CCU018) approved by the CVD-COVID-UK / COVID-IMPACT Approvals & Oversight Board (sub-project: CCU018_01).

## License

Licensed under the Apache License, Version 2.0 (the "License"); you may not use this software except in compliance with the License. You may obtain a copy of the License at http://www.apache.org/licenses/LICENSE-2.0. Unless required by applicable law or agreed to in writing, software distributed under the License is distributed on an "AS IS" BASIS, WITHOUT WARRANTIES OR CONDITIONS OF ANY KIND, either express or implied. See the License for the specific language governing permissions and limitations under the License.
